1. Academic Validation
  2. The aquaporin-4 inhibitor AER-271 blocks acute cerebral edema and improves early outcome in a pediatric model of asphyxial cardiac arrest

The aquaporin-4 inhibitor AER-271 blocks acute cerebral edema and improves early outcome in a pediatric model of asphyxial cardiac arrest

  • Pediatr Res. 2019 Mar;85(4):511-517. doi: 10.1038/s41390-018-0215-5.
Jessica S Wallisch 1 2 3 Keri Janesko-Feldman 3 Henry Alexander 3 Ruchira M Jha 1 3 George W Farr 4 Paul R McGuirk 4 Anthony E Kline 3 5 Travis C Jackson 1 3 Marc F Pelletier 4 Robert S B Clark 1 2 3 6 Patrick M Kochanek 1 2 3 6 Mioara D Manole 7 8 9
Affiliations

Affiliations

  • 1 Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • 2 Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA.
  • 3 Safar Center for Resuscitation Research, Pittsburgh, PA, USA.
  • 4 Aeromics, Inc, Cleveland, OH, USA.
  • 5 Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA.
  • 6 Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA.
  • 7 Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA. mioara.manole@chp.edu.
  • 8 Safar Center for Resuscitation Research, Pittsburgh, PA, USA. mioara.manole@chp.edu.
  • 9 Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA, USA. mioara.manole@chp.edu.
Abstract

Background: Cerebral edema after cardiac arrest (CA) is associated with increased mortality and unfavorable outcome in children and adults. Aquaporin-4 mediates cerebral water movement and its absence in models of ischemia improves outcome. We investigated early and selective pharmacologic inhibition of aquaporin-4 in a clinically relevant asphyxial CA model in immature rats in a threshold CA insult that produces primarily cytotoxic edema in the absence of blood-brain barrier permeability.

Methods: Postnatal day 16-18 Sprague-Dawley rats were studied in our established 9-min asphyxial CA model. Rats were randomized to aquaporin-4 inhibitor (AER-271) vs vehicle treatment, initiated at return of spontaneous circulation. Cerebral edema (% brain water) was the primary outcome with secondary assessments of the Neurologic Deficit Score (NDS), hippocampal neuronal death, and neuroinflammation.

Results: Treatment with AER-271 ameliorated early cerebral edema measured at 3 h after CA vs vehicle treated rats. This treatment also attenuated early NDS. In contrast to rats treated with vehicle after CA, rats treated with AER-271 did not develop significant neuronal death or neuroinflammation as compared to sham.

Conclusion: Early post-resuscitation aquaporin-4 inhibition blocks the development of early cerebral edema, reduces early neurologic deficit, and blunts neuronal death and neuroinflammation post-CA.

Figures
Products